Deutsche Bank’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12M | Buy |
159,891
+10,448
| +7% | +$825K | ﹤0.01% | 999 |
|
|
2025
Q4 | $11.8M | Buy |
149,443
+60,640
| +68% | +$4.57M | ﹤0.01% | 1026 |
|
|
2025
Q3 | $5.81M | Buy |
88,803
+3,525
| +4% | +$172K | ﹤0.01% | 1253 |
|
|
2025
Q2 | $3.37M | Buy |
85,278
+468
| +0.6% | +$15.3K | ﹤0.01% | 1431 |
|
|
2025
Q1 | $2.56M | Sell |
84,810
-7,091
| -8% | -$232K | ﹤0.01% | 1585 |
|
|
2024
Q4 | $3.21M | Buy |
91,901
+17,027
| +23% | +$636K | ﹤0.01% | 1560 |
|
|
2024
Q3 | $3M | Buy |
74,874
+65,778
| +723% | +$3.06M | ﹤0.01% | 1523 |
|
|
2024
Q2 | $434K | Buy |
9,096
+508
| +6% | +$20.8K | ﹤0.01% | 2400 |
|
|
2024
Q1 | $372K | Sell |
8,588
-27,114
| -76% | -$1.29M | ﹤0.01% | 2492 |
|
|
2023
Q4 | $1.81M | Buy |
35,702
+26,213
| +276% | +$1.26M | ﹤0.01% | 1729 |
|
|
2023
Q3 | $430K | Buy |
9,489
+63
| +0.7% | +$2.6K | ﹤0.01% | 2264 |
|
|
2023
Q2 | $387K | Sell |
9,426
-36,300
| -79% | -$1.39M | ﹤0.01% | 2499 |
|
|
2023
Q1 | $1.63M | Sell |
45,726
-20,899
| -31% | -$785K | ﹤0.01% | 1799 |
|
|
2022
Q4 | $2.52M | Buy |
66,625
+1,199
| +2% | +$50.4K | ﹤0.01% | 1527 |
|
|
2022
Q3 | $2.89M | Buy |
65,426
+32,961
| +102% | +$1.39M | ﹤0.01% | 1444 |
|
|
2022
Q2 | $1.2M | Sell |
32,465
-897
| -3% | -$33.8K | ﹤0.01% | 2055 |
|
|
2022
Q1 | $1.24M | Buy |
33,362
+19,275
| +137% | +$631K | ﹤0.01% | 2222 |
|
|
2021
Q4 | $428K | Sell |
14,087
-36,859
| -72% | -$1.16M | ﹤0.01% | 2936 |
|
|
2021
Q3 | $1.71M | Sell |
50,946
-183,440
| -78% | -$6.91M | ﹤0.01% | 2222 |
|
|
2021
Q2 | $9.35M | Buy |
234,386
+73,819
| +46% | +$2.89M | ﹤0.01% | 1213 |
|
|
2021
Q1 | $7.22M | Buy |
160,567
+4,744
| +3% | +$265K | ﹤0.01% | 1359 |
|
|
2020
Q4 | $8.81M | Sell |
155,823
-103,794
| -40% | -$5.17M | 0.01% | 1092 |
|
|
2020
Q3 | $12.3M | Buy |
259,617
+80,072
| +45% | +$4.45M | 0.01% | 892 |
|
|
2020
Q2 | $10.6M | Buy |
179,545
+31,415
| +21% | +$1.75M | 0.01% | 954 |
|
|
2020
Q1 | $7M | Sell |
148,130
-188,452
| -56% | -$10.5M | 0.01% | 1069 |
|
|
2019
Q4 | $20.3M | Buy |
336,582
+139,513
| +71% | +$8.31M | 0.01% | 782 |
|
|
2019
Q3 | $11.8M | Sell |
197,069
-735,664
| -79% | -$47.9M | 0.01% | 1001 |
|
|
2019
Q2 | $59.9M | Buy |
932,733
+830,014
| +808% | +$58.7M | 0.04% | 496 |
|
|
2019
Q1 | $8.34M | Buy |
102,719
+47,722
| +87% | +$3.08M | 0.01% | 1504 |
|
|
2018
Q4 | $2.97M | Sell |
54,997
-112,039
| -67% | -$5.71M | ﹤0.01% | 2141 |
|
|
2018
Q3 | $8.62M | Sell |
167,036
-67,124
| -29% | -$3.15M | ﹤0.01% | 1773 |
|
|
2018
Q2 | $9.76M | Sell |
234,160
-122,400
| -34% | -$5.43M | ﹤0.01% | 1773 |
|
|
2018
Q1 | $15.7M | Buy |
356,560
+184,447
| +107% | +$9.37M | 0.01% | 1280 |
|
|
2017
Q4 | $8.65M | Sell |
172,113
-1,169,620
| -87% | -$64.1M | 0.01% | 1607 |
|
|
2017
Q3 | $68M | Buy |
1,341,733
+862,794
| +180% | +$45.2M | 0.05% | 431 |
|
|
2017
Q2 | $24.4M | Sell |
478,939
-52,933
| -10% | -$2.46M | 0.02% | 833 |
|
|
2017
Q1 | $21.4M | Sell |
531,872
-178,748
| -25% | -$8.03M | 0.02% | 848 |
|
|
2016
Q4 | $34M | Sell |
710,620
-76,895
| -10% | -$3.04M | 0.03% | 625 |
|
|
2016
Q3 | $28.9M | Sell |
787,515
-321,835
| -29% | -$10.1M | 0.02% | 742 |
|
|
2016
Q2 | $25.8M | Buy |
1,109,350
+350,724
| +46% | +$11.3M | 0.02% | 800 |
|
|
2016
Q1 | $30.7M | Buy |
758,626
+61,952
| +9% | +$2.52M | 0.02% | 697 |
|
|
2015
Q4 | $43.1M | Sell |
696,674
-626,771
| -47% | -$33.8M | 0.03% | 575 |
|
|
2015
Q3 | $53.5M | Buy |
1,323,445
+260,688
| +25% | +$13.5M | 0.04% | 472 |
|
|
2015
Q2 | $61.2M | Buy |
1,062,757
+55,275
| +5% | +$3.51M | 0.04% | 482 |
|
|
2015
Q1 | $64.1M | Buy |
1,007,482
+78,804
| +8% | +$5.35M | 0.04% | 475 |
|
|
2014
Q4 | $57.3M | Buy |
928,678
+382,446
| +70% | +$18.9M | 0.04% | 533 |
|
|
2014
Q3 | $21.2M | Sell |
546,232
-136,662
| -20% | -$4.84M | 0.01% | 926 |
|
|
2014
Q2 | $23.5M | Buy |
682,894
+306,792
| +82% | +$9.66M | 0.02% | 847 |
|
|
2014
Q1 | $16.3M | Buy |
376,102
+19,380
| +5% | +$939K | 0.01% | 1053 |
|
|
2013
Q4 | $14.2M | Sell |
356,722
-374,721
| -51% | -$13.4M | 0.01% | 1117 |
|
|
2013
Q3 | $27.5M | Buy |
731,443
+534,281
| +271% | +$16M | 0.02% | 741 |
|
|
2013
Q2 | $5.3M | Buy |
+197,162
| New | +$4.19M | ﹤0.01% | 1582 |
|
Other funds holding IONS
VPM
VCM
Deutsche Bank's IONS Position: Q1 2026 in Review
Deutsche Bank increased its Ionis Pharmaceuticals (IONS) stake by 7% in Q1 2026, buying an estimated $825K and bringing the position to 159,891 shares worth $12M. The position accounts for ﹤0.01% of the portfolio, ranked #999.
Deutsche Bank first reported a position in IONS in Q2 2013 and has held it in 52 quarters since. The position peaked at $68M in Q3 2017. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- Deutsche Bank held 159,891 shares of Ionis Pharmaceuticals worth $12M as of Q1 2026.
- Deutsche Bank bought 10,448 Ionis Pharmaceuticals shares in Q1 2026, an estimated $825K.
- Ionis Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #999 holding.
- Deutsche Bank first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Deutsche Bank's Ionis Pharmaceuticals position peaked at $68M in Q3 2017.
- 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.